Immunogen | Interessi Passivi Sul Debito



Interessi Passivi Sul Debito Cambiamento Data
AbbVie USD 740M 40M 2025-06
Agios Pharmaceuticals USD 1.39B 85.53M 2025-09
Amgen USD 653M 32M 2025-12
Astellas Pharma JPY 3.91B 320M 2025-03
AstraZeneca USD 484M 181M 2025-12
Bristol-Myers Squibb USD 432M 48M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
Exelixis USD 23.4M 3.9M 2023-09
Halozyme Therapeutics USD 4.91M 615K 2025-12
Heron Therapeutics USD 500K 900K 2024-09
Intrexon USD 2K 5K 2024-06
Karyopharm Therapeutics USD 11.38M 2.43M 2024-09
MacroGenics USD 3.34M 2.54M 2025-09
Nektar Therapeutics USD 6.02M 420K 2024-09
Novartis USD 281M 8M 2025-09
Pfizer USD 711M 59M 2025-12
Regeneron Pharmaceuticals USD 12.2M 7.1M 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR -25M 99.78M 2025-12


Immunogen Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.